Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

Paolo Romita; Caterina Foti; Gianluca Calianno; Andrea Chiricozzi

doi:10.1111/dth.15610

Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

Paolo Romita^*
, Caterina Foti
, Gianluca Calianno
, Andrea Chiricozzi

^*Autore corrispondente per questo lavoro

Facoltà di Medicina e Chirurgia "A.Gemelli"

University of Bari

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	e15610-N/A
Rivista	Dermatologic Therapy
Volume	35
Numero di pubblicazione	8
DOI	https://doi.org/10.1111/dth.15610
Stato di pubblicazione	Pubblicato - 2022

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

Dermatologia

Keywords

Antibodies
Antirheumatic Agents
Arthritis
HIV Infections
Humanized
Humans
Monoclonal
Psoriatic
Thalidomide
Treatment Outcome

Accesso al documento

10.1111/dth.15610

Altri file e collegamenti

Cita questo

@article{5bf89a5a161745ddb10409a0aeab654e,

title = "Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast",

keywords = "Antibodies, Antirheumatic Agents, Arthritis, HIV Infections, Humanized, Humans, Monoclonal, Psoriatic, Thalidomide, Treatment Outcome, Antibodies, Antirheumatic Agents, Arthritis, HIV Infections, Humanized, Humans, Monoclonal, Psoriatic, Thalidomide, Treatment Outcome",

author = "Paolo Romita and Caterina Foti and Gianluca Calianno and Andrea Chiricozzi",

year = "2022",

doi = "10.1111/dth.15610",

language = "English",

volume = "35",

pages = "e15610--N/A",

journal = "Dermatologic Therapy",

issn = "1396-0296",

publisher = "John Wiley and Sons Inc",

number = "8",

}

TY - JOUR

T1 - Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

AU - Romita, Paolo

AU - Foti, Caterina

AU - Calianno, Gianluca

AU - Chiricozzi, Andrea

PY - 2022

Y1 - 2022

KW - Antibodies

KW - Antirheumatic Agents

KW - Arthritis

KW - HIV Infections

KW - Humanized

KW - Humans

KW - Monoclonal

KW - Psoriatic

KW - Thalidomide

KW - Treatment Outcome

KW - Antibodies

KW - Antirheumatic Agents

KW - Arthritis

KW - HIV Infections

KW - Humanized

KW - Humans

KW - Monoclonal

KW - Psoriatic

KW - Thalidomide

KW - Treatment Outcome

UR - https://publicatt.unicatt.it/handle/10807/214031

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85131325919&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85131325919&origin=inward

U2 - 10.1111/dth.15610

DO - 10.1111/dth.15610

M3 - Article

SN - 1396-0296

VL - 35

SP - e15610-N/A

JO - Dermatologic Therapy

JF - Dermatologic Therapy

IS - 8

ER -